Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.05Last Year’s EPS
0.09Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 25, 2025
|% Change Since: 24.44%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
AdaptHealth demonstrated notable achievements by exceeding financial guidance and reducing debt significantly, while also extending a major capitated contract with Humana. However, challenges remain with the Diabetes Health segment continuing to decline and flat overall revenue growth. The outlook for 2025 includes potential negative growth, though efforts to improve segments and operational performance are underway.Company Guidance
During the AdaptHealth Fourth Quarter 2024 Earnings Release call, the company reported that key financial metrics such as revenue, adjusted EBITDA, and free cash flow all exceeded the high end of their guidance ranges for the fourth quarter. The company achieved a revenue growth of 3% above the midpoint of their Q4 guidance range, with the Sleep Health and Respiratory Health segments growing by 3.4% and 1%, respectively. However, the Diabetes Health segment saw a decline of 7.3%. The adjusted EBITDA margin was slightly narrower at 23.4% compared to 23.8% in the prior year quarter, while free cash flow increased to $73 million, up 10% year-over-year. AdaptHealth also highlighted their strategic focus on initiatives such as the One Adapt program and the application of AI and automation, with the aim of enhancing service quality and operational efficiency. The company announced a multi-year extension of their capitated contract with Humana and noted a reduction in their net leverage ratio to 2.8x, following a $170 million debt reduction over the year. For 2025, AdaptHealth guided for revenue in the range of $3.22 billion to $3.36 billion, with an expected adjusted EBITDA margin of approximately 21% and free cash flow between $180 million to $220 million.Exceeded Financial Guidance
Revenue, adjusted EBITDA, and free cash flow exceeded the high end of guidance ranges for Q4 2024.
Segment Revenue Growth
Sleep Health revenue increased by 3.4% and Respiratory Health by 1% year-over-year in Q4 2024.
Strong Free Cash Flow
Q4 2024 free cash flow was $73 million, up 10% from the prior year quarter.
Debt Reduction
Reduced debt by $170 million in 2024, including a $50 million reduction in Q4, with a net leverage ratio of 2.8x.
Capitated Contract Extension
Extended a multi-year capitated contract with Humana, indicating strong performance and confidence in the company's management of patient care.
---
AHCO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AHCO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 25, 2025 | $8.55 | $10.64 | +24.44% |
| Nov 05, 2024 | $10.15 | $9.18 | -9.56% |
| Aug 06, 2024 | $10.97 | $8.66 | -21.06% |
| May 07, 2024 | $10.60 | $9.76 | -7.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does AdaptHealth (AHCO) report earnings?
AdaptHealth (AHCO) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is AdaptHealth (AHCO) earnings time?
AdaptHealth (AHCO) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AHCO EPS forecast?
AHCO EPS forecast for the fiscal quarter 2025 (Q1) is 0.05.
---
